Latest Organofluorides Stories
The study’s publication comes as hundreds of people pursue Risperdal lawsuits for complications allegedly associated with the drug, including gynecomastia (male breast growth). New
- Results from two large trials individually showed an improvement in the secondary endpoint of overall survival for patients with the most common EGFR mutation (Del19) RIDGEFIELD, Conn., Jan.
As off-label antipsychotic use is mounting so, too, is litigation associated with specific atypical antipsychotics Port Washington, New York (PRWEB) January
RALEIGH, N.C., Jan. 8, 2015 /PRNewswire/ -- Sprout Pharmaceuticals will participate in the 33rd Annual J.P. Morgan Healthcare Conference to be held January 12 - 15, 2015, in San Francisco.
The Firm is currently representing numerous U.S.
Honeywell's Baton Rouge, Louisiana, manufacturing facility is producing HFO-1234ze for aerosols, extruded polystyrene and refrigerants applications MORRIS TOWNSHIP, N.J., Jan.
RALEIGH, N.C., Jan. 6, 2015 /PRNewswire/ -- Sprout Pharmaceuticals today announced that Cindy Whitehead has been named CEO, effective immediately.
NEW YORK, Jan. 5, 2015 /PRNewswire/ -- Exelixis, Inc. (NASDAQ: EXEL) is a biotechnology company that develops and markets treatments for cancer.
The Firm is actively filing Risperdal gynecomastia claims in the Philadelphia proceeding, all of which allege that the medication caused men and boys to experience excessive breast growth.
- Large; stout; burly.